Methylmalonicacidemia with homocystinuria, cbl D

From WikiMD's Wellness Encyclopedia

Methylmalonicacidemia with homocystinuria, cbl D is a rare genetic disorder that affects the body's ability to process certain parts of proteins and fats. This condition is part of a group of disorders known as cobalamin (vitamin B12) related disorders, specifically classified under the cobalamin D (cblD) variant. It is characterized by the accumulation of methylmalonic acid and homocysteine in the blood, which can lead to a variety of health issues.

Causes[edit | edit source]

Methylmalonicacidemia with homocystinuria, cbl D is caused by mutations in the MMADHC gene. This gene is essential for the proper processing of vitamin B12, which is crucial for the metabolism of fats and proteins. Mutations in the MMADHC gene disrupt the normal function of vitamin B12, leading to the accumulation of toxic substances in the body.

Symptoms[edit | edit source]

The symptoms of methylmalonicacidemia with homocystinuria, cbl D can vary widely among affected individuals. Common symptoms include:

Early detection and treatment are crucial to managing the symptoms and preventing severe complications.

Diagnosis[edit | edit source]

Diagnosis of methylmalonicacidemia with homocystinuria, cbl D typically involves a combination of clinical evaluation and laboratory testing. Blood tests measuring the levels of methylmalonic acid and homocysteine are key to identifying this disorder. Genetic testing can confirm the diagnosis by identifying mutations in the MMADHC gene.

Treatment[edit | edit source]

There is no cure for methylmalonicacidemia with homocystinuria, cbl D, but treatment focuses on managing symptoms and preventing complications. Treatment strategies may include:

  • Dietary restrictions to limit the intake of certain proteins and fats
  • Supplementation with vitamin B12, if responsive
  • Medications to control symptoms such as anemia and to reduce homocysteine levels
  • Regular monitoring for potential complications

Prognosis[edit | edit source]

The prognosis for individuals with methylmalonicacidemia with homocystinuria, cbl D varies. Early diagnosis and treatment can improve the quality of life and lifespan of affected individuals. However, the disorder can lead to serious complications without proper management.



This metabolic pathology related article is a stub. You can help WikiMD by expanding it.

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.com/w/index.php?title=Methylmalonicacidemia_with_homocystinuria,_cbl_D&oldid=5470228"

Contributors: Prab R. Tumpati, MD